The B-Together study explores the potential of bepirovirsen in modulating immune responses to enhance the clearance of HBV-infected hepatocytes. This research highlights a promising step toward achieving a functional cure for chronic hepatitis B through targeted immunomodulation.

Read the full article: https://link.springer.com/article/10.1007/s12072-025-10917-0

#HepatitisB#HBVResearch#Immunotherapy#Hepatology#LiverDisease#Bepirovirsen#HepatologyInternational#ViralHepatitis#ClinicalResearch#HealthcareProfessionals